NCT02411968View on ClinicalTrials.gov

Follow up After Cryoablation of Small Renal Masses.

CompletedOBSERVATIONAL
Enrollment

9

Participants

Timeline

Start Date

February 28, 2015

Primary Completion Date

September 30, 2018

Study Completion Date

September 30, 2018

Conditions
Carcinoma, Renal Cell
Interventions
OTHER

111In-Girentuximab DOTA SPECT

Trial Locations (1)

6500HB

Radboud University Medical Center, Nijmegen

All Listed Sponsors
lead

Radboud University Medical Center

OTHER

NCT02411968 - Follow up After Cryoablation of Small Renal Masses. | Biotech Hunter | Biotech Hunter